サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1259956

インターベンショナルオンコロジーの世界市場の規模、シェア、成長分析：治療別、がんタイプ別、エンドユーザー別、処置別、製品タイプ別 - 業界予測（2022年～2028年）

Global Interventional Oncology Market Size, Share, Growth Analysis, By Therapy, By Cancer Type, By End-User, By Procedure([Embolization ), By Product Type - Industry Forecast 2022-2028
出版日: | 発行: SkyQuest | ページ情報: 英文 165 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
インターベンショナルオンコロジーの世界市場の規模、シェア、成長分析：治療別、がんタイプ別、エンドユーザー別、処置別、製品タイプ別 - 業界予測（2022年～2028年）
出版日: 2022年11月05日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のインターベンショナルオンコロジーの市場規模は、2021年の21億5,000万米ドルから2028年までに36億5,000万米ドルに達し、予測期間（2022年～2028年）にCAGRで5.09%の成長が予測されています。従来の治療法に比べて大きな利点があるため、低侵襲治療に対する需要が近年劇的に拡大しています。

当レポートでは、世界のインターベンショナルオンコロジー市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場の分析

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリックス
  • パイプライン製品の分析
  • マクロ経済指標

COVIDの影響

  • イントロダクション
  • 経済シナリオに対する影響の評価
  • 修正された市場規模
  • 主要セグメントに対するCOVIDの影響
  • COVID戦略：企業別

市場力学と見通し

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制情勢
  • SWOT分析
  • ポーターのファイブフォース分析
  • 将来の混乱についての特別な考察

世界のインターベンショナルオンコロジー市場：治療別

  • 市場セグメント
  • 放射線治療
  • アブレーションデバイス
  • 粒子塞栓デバイス

世界のインターベンショナルオンコロジー市場：がんタイプ別

  • 市場セグメント
  • 肝臓がん
  • 腎がん
  • 肺がん
  • その他

世界のインターベンショナルオンコロジー市場：エンドユーザー別

  • 市場セグメント
  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

世界のインターベンショナルオンコロジー市場：処置別

  • 市場セグメント
  • 塞栓（TARE、TACE）
  • アブレーション（サーマルアブレーション（マイクロ波、RFアブレーション））

世界のインターベンショナルオンコロジー市場：製品タイプ別

  • 市場セグメント
  • 塞栓デバイス
  • アブレーションデバイス
  • サポートデバイス

市場規模：地域別

  • 北米
  • 米国
  • カナダ
  • 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • ブラジル
  • その他の南米
  • 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

主要企業プロファイル

  • 競合情勢
  • 含まれる企業の総数
  • 主要企業の市場ポジショニング
  • 主要企業の市場シェア
  • Medtronic (Ireland)
  • Boston Scientific (US)
  • BD (US)
  • Terumo (Japan)
  • Merit Medical (US)
  • AngioDynamics (US)
  • J&J (US)
  • Teleflex (US)
  • Cook Medical (US)
  • HealthTronics (US)
  • MedWaves (US)
  • Sanarus (US)
  • IMBiotechnologies (Canada)
  • Trod Medical (US)
  • IceCure Medical (Israel)
  • Mermaid Medicals (Denmark)
  • Interface Biomaterials BV (Netherlands)
  • Guerbet (France)
  • ABK Biomedical (Canada)
  • Shape Memory Medical (US)
  • Endo Shape (US)
  • Monteris Medical (US)
  • Instylla (US)
  • Trisalus Lifesciences (US)
  • Profound Medical Corp (Canada)
  • Sirtex (US)
  • Accuray (US)
  • Baylis Medical (Canada)
  • ALPINION MEDICAL SYSTEMS (South Korea)
目次
Product Code: SQSG30G2030

Global Interventional oncology Market was valued at USD 2.15 billion in 2021 and it is expected to reach at USD 3.65 billion by 2028, at a CAGR of 5.09% over the forecast period (2022-2028).

Interventional oncology (IO) is a subspecialty of interventional radiology that focuses on the treatment and diagnosis of cancer and cancer-related disorders using image-guided minimally invasive procedures. Interventional oncologists deal with patients in the infirmary, admit them to hospitals, and serve on the tumour review board and multidisciplinary treatment team, all while actively working on cancer diagnosis and administration. Alongside medical, surgical, and radiation oncology, the fast emerging discipline of interventional oncology has evolved into a foundation of cancer care. The global Interventional Oncology Market is expanding mostly as a result of companies resuming operations and adjusting to the new normal while recovering from the effects of COVID-19. Furthermore, the rising usage of interventional oncology approaches to identify and treat cancer using minimally invasive techniques and enhanced imaging technologies is fueling the devices market, which is expected to rise significantly during the estimated period. Furthermore, with increased market competition, the rapid use of new technologies to improve healthcare has positively influenced market growth.

Interventional oncology offers patients more therapeutic alternatives. Furthermore, while surgical excision of tumours is widely acknowledged to be the most effective long-term therapy, it is not always possible due to tumour size, amount, or location. Interventional oncology (IO) therapies are frequently utilised to shrink tumours, allowing for surgery or interventional therapy. Interventional oncology techniques are generally separated into diagnostic therapies that aid in the tissue diagnosis of suspected neoplasms and therapeutic procedures that attempt to cure or reduce the tumour. The advantage of these operations is that they have a far smaller impact on the rest of the body and the organ being treated. It also has a quicker recovery period than traditional open surgeries. Interventional Oncology therapy can be extremely beneficial to patients. Because the therapies are less invasive, they are less painful, have less side effects, and require less time to recover from. Several IO therapies can be conducted as outpatient operations, freeing up hospital beds and cutting costs. Funding from the public and private sectors aids in the development of new technologies and equipment, propelling the Interventional Oncology Market forward. Product recalls, on the other hand, are expected to weaken demand for interventional oncology equipment. Additionally, the lack of scientific evidence for limited area therapy and strict regulation will stymie market growth.

Additionally, a scarcity of well-trained and skilled oncologists, as well as a lack of clinical evidence to support treatment success, may pose a threat to market expansion. Furthermore, emerging economies offer tremendous growth potential for the business. Accelerated economic development and increased healthcare spending in some emerging economies are expected to improve access to high-quality care.

Top-down and bottom-up approaches were used to estimate and validate the size of global Interventional oncology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global Interventional Oncology market is segmented based on Therapy, Cancer Type, End-User, Product Type, Procedures, Product Type, and Region. Based on Therapy the market is segmented into Radiation Therapy, Ablation Devices, Particle Embolization Devices. Based on End-User the market is segmented into Hospitals, Ambulatory surgical centres, Specialty clinics, Others. Based on Procedure the market is segmented into [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))]. Based on Cancer Type the market is segmented into Liver Cancer, Kidney Cancer, Lung Cancer, Others. Based on Product Type the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. Based on region the global Interventional Oncology market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

Patients' Demand for Least Invasive Treatments is Increasing

Because of the considerable advantages that these approaches have over traditional treatment methods, the demand for minimally invasive treatments has expanded dramatically in recent years. The key benefits of minimally invasive therapies are fewer operational complications, shorter hospitalisation, less discomfort, smaller and more cosmetic incisions, a decreased risk of infection, less post-surgical care, and faster recovery. Advanced technologies are utilised in minimally invasive therapies to identify and treat a number of illnesses, including cancer. These methods are utilised to remove cancer tumours and lymph nodes while leaving no visible scars. Less invasive methods also assist surgeons in collecting tissue for biopsy and staging examinations. As a result, surgeons can devise a more specific cancer treatment strategy. Less invasive techniques also result in significant cost reductions. Leading interventional oncology market participants are increasingly emphasising the introduction of innovative technologically sophisticated products. This market's innovation is focused on generating cost-effective, technologically complex, and simple-to-use interventional oncology solutions. These improvements aim to improve the efficiency of interventional oncology systems while also widening their application areas, hence raising end-user demand for these systems.

Restraint

There is a scarcity of highly skilled and experienced radiologists and oncologists.

The interventional oncology business is always undergoing technological advances and enhancements to improve the accuracy and specificity of equipment and treatments. Yet, interventional oncology is a method that requires full-time professionals to achieve and maintain high standards. As a result, the interventional oncology business is likely to face a shortage of well-trained and skilled radiologists and oncologists. In the United States, for example, a shortage of more than 2,300 medical oncologists is expected by 2025. (Source: Journal of Global Oncology). This element will have a stronger influence on developing and disadvantaged regions. One of the most significant obstacles in providing care for patients with curable tumours in Sub-Saharan Africa is a scarcity of medical oncologists, radiation oncologists, and other cancer-care experts. Similarly, there is a serious shortage of oncologists, radiotherapists, and surgical oncologists in India. In a country with 1.8 million cancer patients, only one oncologist treats every 2,000 patients. Despite the availability of a large target patient population, the paucity of oncologists and radiologists in many countries throughout the world is expected to have an impact on the adoption of interventional oncology procedures in their respective healthcare systems.

Market Trends

The organisations are currently focusing on enhancing performance by combining robotics technology into interventional oncology equipment. Robotic systems have enhanced accuracy and efficiency by combining image-based planning and navigation with the installation of various instruments for the targeted body part. Furthermore, the rapid rise in cancer incidence worldwide, combined with a growing need for less intrusive therapy, is driving market expansion throughout the forecast period. Furthermore, rising government and private funding for cancer research, particularly for treatment devices that encourage early detection and improve survival rates, has fueled market expansion. Interventional Oncology therapy can be extremely beneficial to patients.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global Interventional Oncology Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
  • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
  • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
  • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
  • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
  • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
  • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
  • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
  • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
  • Exhibit: Data Table on Global Global Interventional Oncology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
  • Competitive rivalry
  • Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
  • Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
  • Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
  • Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
  • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
  • Political Impact
  • Economic impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Global Interventional Oncology Market by Therapy
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Radiation Therapy
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Ablation Devices
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Particle Embolization Devices
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Interventional Oncology Market by Cancer Type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Liver Cancer
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Kidney Cancer
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Lung Cancer
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Interventional Oncology Market by End-User
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Hospitals
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Ambulatory surgical centres
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Specialty clinics
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Interventional Oncology Market by Procedure
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • [Embolization (TARE, TACE)
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Ablation (Thermal Ablation (Microwave, RF Ablation))]
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Interventional Oncology Market by Product Type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Embolization Devices
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Ablation Devices
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Support Devices
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Canada
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Spain
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • France
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • UK
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Europe
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • India
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Japan
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Korea
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Asia Pacific
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of South America
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Africa
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of MEA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
  • Total number of companies covered
  • Exhibit: companies covered in the report, 2021
  • Top companies market positioning
  • Exhibit: company positioning matrix, 2021
  • Top companies market Share
  • Exhibit: Pie chart analysis on company market share, 2021(%)
  • Medtronic (Ireland)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Boston Scientific (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • BD (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Terumo (Japan)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Merit Medical (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • AngioDynamics (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • J&J (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Teleflex (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Cook Medical (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • HealthTronics (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • MedWaves (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Sanarus (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • IMBiotechnologies (Canada)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Trod Medical (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • IceCure Medical (Israel)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Mermaid Medicals (Denmark)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Interface Biomaterials BV (Netherlands)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Guerbet (France)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • ABK Biomedical (Canada)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Shape Memory Medical (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Endo Shape (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Monteris Medical (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Instylla (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Trisalus Lifesciences (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Profound Medical Corp (Canada)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Sirtex (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Accuray (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Baylis Medical (Canada)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • ALPINION MEDICAL SYSTEMS (South Korea)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments